Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 3 (March)

1. Anemia with impaired erythropoietin response in diabetic patients.
   Arch Intern Med, 165(4): 466-9. [Abstract] [Full-text]
2. Gastropathic sideropenia.
   Best Pract Res Clin Haematol, 18(2): 363-80. [Abstract] [Full-text]
3. The impact of iron fortification on nutritional anaemia.
   Best Pract Res Clin Haematol, 18(2): 333-46. [Abstract] [Full-text]
4. Diagnosis and management of iron-deficiency anaemia.
   Best Pract Res Clin Haematol, 18(2): 319-32. [Abstract] [Full-text]
5. LPI-labile plasma iron in iron overload.
   Best Pract Res Clin Haematol, 18(2): 277-87. [Abstract] [Full-text]
6. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia.
   Best Pract Res Clin Haematol, 18(2): 251-63. [Abstract] [Full-text]
7. Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages.
   Best Pract Res Clin Haematol, 18(2): 171-82. [Abstract] [Full-text]
8. Attaching-effacing lesions associated with Escherichia coli O157:H7 and other bacteria in experimentally infected conventional neonatal goats.
   J Comp Pathol, 132(2): 185-94. [Abstract] [Full-text]
9. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
   Am J Hematol, 78(3): 203-6. [Abstract] [Full-text]
10. Iron deficiency: a concise review.
    Am J Hematol, 78(3): 225-31. [Abstract] [Full-text]
11. Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70.
    Am J Hematol, 78(3): 240-2. [Abstract] [Full-text]
12. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Am J Hematol, 78(3): 243-4. [Abstract] [Full-text]
13. Intracerebral hemorrhage in the iron-deficient rat.
    Stroke, 36(3): 660-4. [Abstract] [Full-text]
14. Asthma in children with sickle cell disease and its association with acute chest syndrome.
    Thorax, 60(3): 206-10. [Abstract] [Full-text]
15. Prenatal cardiovascular manifestations in the twin-to-twin transfusion syndrome recipients and the impact of therapeutic amnioreduction.
    Am J Obstet Gynecol, 192(3): 892-902. [Abstract] [Full-text]
16. Usefulness of brilliant cresyl blue staining as an auxiliary method of screening for alpha-thalassemia.
    J Lab Clin Med, 145(2): 94-7. [Abstract] [Full-text]
17. Management of acquired aplastic anaemia.
    Blood Rev, 19(3): 143-51. [Abstract] [Full-text]
18. Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital.
    Prenat Diagn, 25(2): 163-71. [Abstract] [Full-text]
19. Cerebral venous thrombosis in a patient with Evans syndrome: a rare association.
    Ann Hematol, 84(2): 124-6. [Abstract] [Full-text]
20. Clinical relevance of vascular endothelial growth factor levels in sickle cell disease.
    Ann Hematol, 84(2): 71-5. [Abstract] [Full-text]
21. Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.
    Am J Kidney Dis, 45(3): 588-95. [Abstract] [Full-text]
22. Post-irradiation phosphorylation of structural maintenance chromosome 1 (SMC1) is independent of the Fanconi protein pathway.
    Int J Radiat Oncol Biol Phys, 61(4): 1167-72. [Abstract] [Full-text]
23. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Int J Radiat Oncol Biol Phys, 61(4): 1087-95. [Abstract] [Full-text]
24. Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease.
    Med Clin North Am, 89(3): 549-61. [Abstract] [Full-text]
25. Defining stroke risk in children with sickle cell anaemia.
    Br J Haematol, 128(6): 751-66. [Abstract] [Full-text]
26. Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities.
    Pediatr Radiol, 35(3): 223-8. [Abstract] [Full-text]
27. TCD in sickle cell disease: an important and useful test.
    Pediatr Radiol, 35(3): 229-34. [Abstract] [Full-text]
28. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler.
    Pediatr Radiol, 35(3): 242-8. [Abstract] [Full-text]
29. MRI/MRA evaluation of sickle cell disease of the brain.
    Pediatr Radiol, 35(3): 249-57. [Abstract] [Full-text]
30. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Bone Marrow Transplant, 35(6): 591-4. [Abstract] [Full-text]
31. A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation.
    Chest, 127(3): 928-35. [Abstract] [Full-text]
32. Anemia and inflammation in COPD.
    Chest, 127(3): 825-9. [Abstract] [Full-text]
33. Rosai-Dorfman disease recurrence with bilateral orbital masses following immunosuppressant therapy.
    Orbit, 24(1): 51-3. [Abstract] [Full-text]
34. Coeliac disease as a cause of unusually severe anaemia in a young man with idiopathic pulmonary haemosiderosis.
    Respir Med, 99(4): 451-3. [Abstract] [Full-text]
35. Relationship between renal anemia and prognostic stages of IgA nephropathy.
    J Clin Lab Anal, 19(2): 80-3. [Abstract] [Full-text]
36. Campaign to control genetic blood diseases in Bahrain.
    Community Genet, 8(1): 52-5. [Abstract] [Full-text]
37. Molecular heterogeneity of beta-thalassemia in the United Arab Emirates.
    Community Genet, 8(1): 35-9. [Abstract] [Full-text]
38. Application of a new chemiluminescence method for the determination of glucose-6-phosphate dehydrogenase activity in healthy and enzyme-deficient individuals.
    J Pharmacol Toxicol Methods, 51(2): 169-74. [Abstract] [Full-text]
39. Development of cellular models for ribosomal protein S19 (RPS19)-deficient diamond-blackfan anemia using inducible expression of siRNA against RPS19.
    Mol Ther, 11(4): 627-37. [Abstract] [Full-text]
40. Flucloxacillin-induced aplastic anaemia and liver failure.
    Transpl Int, 18(4): 487-9. [Abstract] [Full-text]
41. Anemia under androgen deprivation: influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system.
    Horm Metab Res, 37(2): 89-93. [Abstract] [Full-text]
42. The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease.
    J Clin Pharmacol, 45(4): 434-45. [Abstract] [Full-text]
43. Chronic toxicity and carcinogenicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin displays a distinct dose/time toxicity threshold (c x t = k) and a life-prolonging subthreshold effect.
    Food Chem Toxicol, 43(5): 729-40. [Abstract] [Full-text]
44. Oral versus high dose parenteral iron supplementation in pregnancy.
    Int J Gynaecol Obstet, 89(1): 7-13. [Abstract] [Full-text]
45. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait.
    Eur J Haematol, 74(4): 333-6. [Abstract] [Full-text]
46. Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis.
    Eur J Haematol, 74(4): 309-14. [Abstract] [Full-text]
47. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.
    Lancet, 365(9464): 1073-86. [Abstract] [Full-text]
48. A humanized mouse model for a common beta0-thalassemia mutation.
    Genomics, 85(4): 453-61. [Abstract] [Full-text]
49. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life.
    Kidney Int, 67(4): 1500-8. [Abstract] [Full-text]
50. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.
    Kidney Int, 67(4): 1483-8. [Abstract] [Full-text]
51. Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination.
    Kidney Int, 67(4): 1476-82. [Abstract] [Full-text]
52. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.
    Blood, 105(7): 2685-90. [Abstract] [Full-text]
53. BMP4 and Madh5 regulate the erythroid response to acute anemia.
    Blood, 105(7): 2741-8. [Abstract] [Full-text]
54. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Transfus Apher Sci, 32(2): 177-84. [Abstract] [Full-text]
55. Molecular crowding limits the role of fetal hemoglobin in therapy for sickle cell disease.
    J Mol Biol, 347(5): 1015-23. [Abstract] [Full-text]
56. Blood lead levels in iron-deficient and noniron-deficient adults.
    Clin Lab Haematol, 27(2): 105-9. [Abstract] [Full-text]
57. Utility of point-of-care haemoglobin measurement in the HemoCue-B haemoglobin for the initial diagnosis of anaemia.
    Clin Lab Haematol, 27(2): 99-104. [Abstract] [Full-text]
58. Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer.
    Acta Oncol, 44(2): 129-33. [Abstract] [Full-text]
59. Postoperative methemoglobinemia with associated G-6-P-D deficiency in infant cardiac surgery--enigmas in diagnosis and management.
    Paediatr Anaesth, 15(4): 334-7. [Abstract] [Full-text]
60. Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations.
    Eur J Hum Genet, 13(4): 513-5. [Abstract] [Full-text]
61. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
    Lab Hematol, 11(1): 14-23. [Abstract] [Full-text]
62. Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin.
    Gynecol Oncol, 97(1): 228-33. [Abstract] [Full-text]
63. Dental arch morphological and dimensional characteristics in Jordanian children and young adults with beta-thalassaemia major.
    Int J Paediatr Dent, 15(2): 98-104. [Abstract] [Full-text]
64. Expression of membrane-bound IL-15 by bone marrow fibroblast-like stromal cells in aplastic anemia.
    Int Immunol, 17(4): 429-37. [Abstract] [Full-text]
65. Missed diagnosis in hematological patients-an autopsy study.
    Virchows Arch, 446(3): 225-31. [Abstract] [Full-text]
66. Increased hemoglobin levels and improved quality-of-life assessments during epoetin alfa treatment in anemic cancer patients: results of a prospective, multicenter German trial.
    Oncologist, 10(3): 225-37. [Abstract] [Full-text]
67. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
    Best Pract Res Clin Haematol, 18(3): 481-9. [Abstract] [Full-text]
68. Immunologic mechanisms of EPO-associated pure red cell aplasia.
    Best Pract Res Clin Haematol, 18(3): 473-80. [Abstract] [Full-text]
69. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Best Pract Res Clin Haematol, 18(3): 467-72. [Abstract] [Full-text]
70. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines.
    Best Pract Res Clin Haematol, 18(3): 455-66. [Abstract] [Full-text]
71. Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review.
    Best Pract Res Clin Haematol, 18(3): 449-54. [Abstract] [Full-text]
72. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Best Pract Res Clin Haematol, 18(3): 439-48. [Abstract] [Full-text]
73. The ASH/ASCO clinical guidelines on the use of erythropoietin.
    Best Pract Res Clin Haematol, 18(3): 433-8. [Abstract] [Full-text]
74. The blue cross blue shield assessment technology review: summary of findings.
    Best Pract Res Clin Haematol, 18(3): 423-31. [Abstract] [Full-text]
75. Anemia and the elderly: clinical considerations.
    Best Pract Res Clin Haematol, 18(3): 417-22. [Abstract] [Full-text]
76. Phase III clinical trials with darbepoetin: implications for clinicians.
    Best Pract Res Clin Haematol, 18(3): 407-16. [Abstract] [Full-text]
77. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
    Best Pract Res Clin Haematol, 18(3): 389-406. [Abstract] [Full-text]
78. The effects of erythrocyte membranes on the nucleation of sickle hemoglobin.
    Biophys J, 88(4): 2815-22. [Abstract] [Full-text]
79. Modeling a hydropic recipient twin in twin-twin transfusion syndrome.
    Am J Physiol Regul Integr Comp Physiol, 288(4): R799-814. [Abstract] [Full-text]
80. Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life support.
    Pediatr Cardiol, 26(1): 104-6. [Abstract] [Full-text]
81. Anemia and HIV in the antiretroviral era: potential significance of testosterone.
    AIDS Res Hum Retroviruses, 21(3): 200-6. [Abstract] [Full-text]
82. Barriers to adherence of deferoxamine usage in sickle cell disease.
    Pediatr Blood Cancer, 44(5): 500-7. [Abstract] [Full-text]
83. Nijmegen breakage syndrome diagnosed as Fanconi anaemia.
    Pediatr Blood Cancer, 44(5): 494-9. [Abstract] [Full-text]
84. Host cell preference and variable transmission strategies in malaria parasites.
    Proc Biol Sci, 272(1562): 511-7. [Abstract] [Full-text]
85. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.
    Nat Genet, 37(4): 435-40. [Abstract] [Full-text]

© 2004-2008 Anemia Research Today. All Rights Reserved.